About Redcare
About Us
Why Redcare?
Facts & Figures
Public Affairs
Our Company
Newsroom
News & Events
Newsletter
Sustainability
Our Impact
Investor Relations
Investor Centre
Overview
Why invest in Redcare Pharmacy
Key Financials
Guidance 2023
Fact Sheet
Share
Share Price
Share Data
Shareholder Structure
Analysts
Analysts Consensus
Convertible Bond
News
Financial News
Ad-hoc Releases
Company News
Events and Publications
Financial Calendar
Publications
Corporate Governance
Managing Board
Supervisory Board
Annual General Meeting
Committees
Documents
Contact
Career
Our Culture
Teams
Jobs
FAQs
DE
EN
DE
EN
About us
Newsroom
Careers
Investor Relations
Sustainability
Loading...
Ad-hoc Releases
2023
2022
2021
2020
Archive
23
May
Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.
11
May
SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted
30
Mar
SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.
15
Mar
SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO
06
Mar
SHOP APOTHEKE EUROPE N.V.: No prolongation of his term as CEO by Stefan Feltens
Show More
Show Less
12
Apr
SHOP APOTHEKE EUROPE: ACQUISITION OF 'FIRST A', A PIONEERING QUICK-COMMERCE PLAYER IN THE GERMAN PHARMACY MARKET.
Show More
Show Less
22
Jul
SHOP APOTHEKE EUROPE: change of forecast for the 2021 financial year
28
Jan
SHOP APOTHEKE EUROPE: Pooling agreement of several shareholders with voting agreement for more than 26% of the voting rights.
14
Jan
SHOP APOTHEKE EUROPE N.V. increases size of the convertible bond offering due to high demand.
14
Jan
SHOP APOTHEKE EUROPE N.V. launches EUR 200 million convertible bonds.
07
Jan
SHOP APOTHEKE EUROPE Acquires Digital Health Provider SMARTPATIENT.
Show More
Show Less
15
Oct
SHOP APOTHEKE EUROPE N.V. ANNOUNCES REDEMPTION OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
06
Oct
SHOP APOTHEKE EUROPE N.V. ENDS DISCUSSIONS AND ANNOUNCES CLEAN-UP OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
30
Sep
SHOP APOTHEKE EUROPE N.V.:
23
Sep
SHOP APOTHEKE EUROPE N.V. ANNOUNCES TO START DISCUSSIONS OF A POSSIBLE EARLIER CONVERSION OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
23
Jul
SHOP APOTHEKE EUROPE raises full year 2020 guidance.
08
Apr
SHOP APOTHEKE EUROPE N.V. successfully completes EUR 65 million capital increase by placing c. 1.12 million new bearer shares with institutional investors on the back of very strong demand.
07
Apr
SHOP APOTHEKE EUROPE N.V. launches an equity offering of new bearer shares by way of an accelerated bookbuild.
Show More
Show Less
10
Apr
SHOP APOTHEKE EUROPE N.V. successfully completes c. EUR 50m capital increase by placing 1.39m new bearer shares and a EUR 60m concurrent tap of its existing convertible bonds due April 2023 with institutional investors.
09
Apr
SHOP APOTHEKE EUROPE N.V. launches an equity offering of new bearer shares by way of an accelerated bookbuild and a concurrent tap issuance of its existing convertible bonds due April 2023.
13
Nov
SHOP APOTHEKE EUROPE: Revised forecast for financial year 2018
17
Sep
SHOP APOTHEKE EUROPE N.V.: Stefan Feltens to strengthen management team with immediate effect; will succeed Michael Köhler, who will resign as chair of the managing board for personal reasons as of 31 December 2018.
13
Jul
SHOP APOTHEKE EUROPE N.V. takes over specialist for functional nutrition products nu3 GmbH, Berlin
12
Apr
SHOP APOTHEKE EUROPE N.V. launches EUR 75 million convertible bonds offering with up to EUR 25 million increase option
25
Sep
SHOP APOTHEKE EUROPE to strengthen European market leadership through the acquisition of mail-order pharmacy Europa Apotheek.
15
Sep
SHOP APOTHEKE EUROPE N.V.: Comment on market rumors regarding a possible takeover by Amazon
11
Oct
SHOP APOTHEKE EUROPE sets IPO price at EUR 28.00 per share
Show More
Show Less
